Abstract:Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts, white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is a critical cause of neuronal loss and synaptic disintegration. Abnormal neuroinflammation, autophagy and apoptosis are the prerequisite factors for endothelial and neuronal cell damage. This leads to the onset and progression of cerebrovascular disorders and cognitive dysfunction. The innate immune cells, pattern recognition receptors, Toll-like receptor-4 and related inflammatory mechanisms disrupt cerebrovascular integrity via glial activation and increased pro-inflammatory interleukins and TNFα. Inflammasome polymorphisms and multi-faceted neuro-immune interactions further integrate systemic and central inflammatory pathways, which induce vascular tissue injury and neurodegeneration. Specifically, chronic cerebral hypoperfusion disrupts the self-cannibalization mechanism of autophagy via altered expression of autophagy-specific proteins, Beclin-1, LC3 and P62. The deregulated autophagy pathway causes neuronal loss, hippocampal shrinkage, and ultimate loss in synaptic plasticity. The vascular dementia models typically exhibit downregulated anti-apoptotic Bcl-2 and upregulated pro-apoptotic Bax, cleaved caspase-3, and cleaved-PARP levels in the brain, for which modulated p38 MAPK and JNK phosphorylation pathways play a vital role. Endoplasmic stress-induced apoptosis, calcium overload and glutamate excitotoxicity in combination with ASK1-MAPK signaling mechanism also contribute to the cerebrovascular pathology. Vascular injury reduces neurological scores and increases the infarct volume, DNA damage and neuronal apoptosis in ischemia/reperfusion injury. Additionally, synergistic and additive interactions between inflammasome, autophagy and apoptotic signaling pathways augment symptoms of vascular neurodegeneration. Overall, the current review enlightens the key risk factors and underlying mechanism triggering vascular dementia. The review additionally informs the challenges associated while treating vascular dysfunction, and highlights the need for targeted drugs for reducing cerebrovascular damage.

Perivascular macrophages in cerebrovascular diseases

Perivascular Macrophages in Thecns: from Health to Neurovascular Diseases

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia

Brain perivascular macrophages: current understanding and future prospects

Perivascular macrophages in health and disease

Microglia and macrophages in the neuro-glia-vascular unit: From identity to functions

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides

Brain microvascular pericytes in health and disease

Inflammation, apoptosis and autophagy as critical players in vascular dementia

Macrophages in vascular disease: Roles of mitochondria and metabolic mechanisms

The elusive brain perivascular fibroblast: a potential role in vascular stability and homeostasis

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer's disease and experimental chronic cerebral hypoperfusion

Endothelial cells and macrophages as allies in the healthy and diseased brain

Cerebral microvascular pericytes and neurogliovascular signaling in health and disease

Cerebral microbleeds in vascular dementia from clinical aspects to host-microbial interaction

Interplay between Brain Pericytes and Endothelial Cells in Dementia

Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects

Role of bone marrow-derived macrophages (BMDMs) in neurovascular interactions during stroke

Emerging Links between Cerebral Blood Flow Regulation and Cognitive Decline: A Role for Brain Microvascular Pericytes